Aspirin protects low density lipoprotein from oxidative modification.

K. A. Steer, T. M. Wallace, C. H. Bolton, M. Hartog

Department of Medicine, University of Bristol.

OBJECTIVE: To examine the effects of aspirin on the potential for oxidative modification of low density lipoprotein (LDL). DESIGN: Before and after trial. SETTING: University department of medicine within a district general hospital campus. PATIENTS: Ten healthy normolipidaemic volunteers drawn from laboratory and medical staff. INTERVENTIONS: Aspirin (enteric coated) 300 mg daily for two weeks. MAIN OUTCOME MEASURES: In vitro oxidation of LDL following ultraviolet C (UVC) irradiation with measurements made of malondialdehyde, conjugated dienes, and electrophoretic mobility. RESULTS: There was a significant decrease in malondialdehyde production from LDL modified by aspirin in vivo following exposure to UVC irradiation for 90 minutes, culminating in a 30% decrease by 240 minutes (mean (SD) 64.2 (9.12) v 89.6 (11.6) nmol/mg LDL protein, P = 0.029). These observations were borne out using LDL modified by aspirin in vitro. The UVC induced increase in relative electrophoretic mobility of LDL was also significantly reduced following aspirin treatment (mean (SD) 2.17 (0.16) v 2.66 (0.24), P = 0.012). CONCLUSIONS: Aspirin, both in vivo and in vitro, protects LDL against subsequent oxidative modification, providing an additional mechanism whereby aspirin may protect against atherosclerosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sanderson, S., Emery, J., Baglin, T., Kinmonth, A.-L. (2005). Narrative Review: Aspirin Resistance and Its Clinical Implications. ANN INTERN MED 142: 370-380 [Abstract] [Full Text]  
• Grosser, N., Schroder, H. (2003). Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway. Arterioscler. Thromb. Vasc. Bio. 23: 1345-1351 [Abstract] [Full Text]  
• Prasad, K., Lee, P. (2003). Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin. J CARDIOVASC PHARMACOL THER 8: 61-69 [Abstract]  
• Bolton, C. H., Downs, L. G., Victory, J. G.G., Dwight, J. F., Tomson, C. R.V., Mackness, M. I., Pinkney, J. H. (2001). Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16: 1189-1197 [Abstract] [Full Text]  
• Durak, I, Karaayvaz, M, Cimen, M Y B, Avci, A, Cimen, O B, Buyukkogak, S, Oztfirk, H S, Ozbek, H., Kagmaz, M (2001). Aspirin impairs antioxidant system and causes peroxidation in human erythrocytes and guinea pig myocardial tissue. Hum Exp Toxicol 20: 34-37 [Abstract]  
• Awtry, E. H., Loscalzo, J. (2000). Aspirin. Circulation 101: 1206-1218 [Full Text]